NextPV Newsletter July 2024
Revised CTIS transparency rules and new version of the public portal.
Concept paper on the revision of the COVID-19 vaccines guidance documents.
Semaglutide linked to higher risk of blinding condition.
Risk of AI getting dumber.
And much more...
You can read the whole newsletter on our website:
If you want to keep up to date with pharmacovigilance regulations, patient safety, advancement in the relevant use of artificial intelligence, and personal growth, subscribe.